Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency.
暂无分享,去创建一个
A. Fischer | A. Plebani | J. Litzman | O. Sanal | Nadia Catalan | I. Tezcan | A. Durandy | P. Lane | P. Quartier | J. Bustamante | G. Aksu | G. Davies | J. Fermand | M. Debré | A. Deville | G. Horneff | I. Yalçın | J. Levy | F. Ersoy | K. Imai | J. Bustamante
[1] A. Fischer,et al. Human uracil–DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination , 2003, Nature Immunology.
[2] A. Fischer,et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. , 2003, The Journal of clinical investigation.
[3] T. Morio,et al. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. , 2003, Journal of medical and dental sciences.
[4] L. Notarangelo,et al. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. , 2003, The Journal of pediatrics.
[5] Massimo Marconi,et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] T. Honjo,et al. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria , 2001, Nature.
[7] S. Kenwrick,et al. Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. , 2001, American journal of medical genetics.
[8] Chi A. Ma,et al. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia , 2001, Nature Immunology.
[9] A. Fischer,et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling , 2001, Nature Genetics.
[10] A. Fischer,et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. , 2000, Clinical immunology.
[11] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[12] A. Fischer,et al. Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2) , 2000, Cell.
[13] M. Taniwaki,et al. Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. , 2000, Genomics.
[14] L. Notarangelo,et al. X‐linked immunodeficiency with hyper‐IgM (XHIM) , 2000, Clinical and experimental immunology.
[15] T. Honjo,et al. Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells* , 1999, The Journal of Biological Chemistry.
[16] H. Ochs,et al. Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. , 1999, The Journal of pediatrics.
[17] K. Rajewsky,et al. Human Immunoglobulin (Ig)M+IgD+ Peripheral Blood B Cells Expressing the CD27 Cell Surface Antigen Carry Somatically Mutated Variable Region Genes: CD27 as a General Marker for Somatically Mutated (Memory) B Cells , 1998, The Journal of experimental medicine.
[18] P. Dent. Spectrum of the X-linked hyper IgM syndrome. , 1998, The Journal of pediatrics.
[19] A. Fischer,et al. Clinical spectrum of X-linked hyper-IgM syndrome. , 1997, The Journal of pediatrics.
[20] A. Fischer,et al. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression. , 1997, Journal of immunology.
[21] F. Kostolanský,et al. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection. , 1997, Acta virologica.
[22] H. Ochs,et al. X-linked agammaglobulinemia. A clinical and molecular analysis. , 1996, Medicine.
[23] A. Villa,et al. CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. , 1996, Immunology today.
[24] A. Durandy,et al. Hyper-IgM syndrome associated with rheumatoid arthritis: report of RA in a patient with primary impaired CD40 pathway. , 1996, British journal of rheumatology.
[25] D. Campana,et al. Hyper IgM syndrome associated with defective CD40-mediated B cell activation. , 1994, The Journal of clinical investigation.
[26] R. Callard,et al. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers. , 1994, Journal of immunology.
[27] J. Belmont,et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome , 1993, Science.
[28] A. Fischer,et al. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM , 1993, Nature.
[29] J. Bajorath,et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome , 1993, Cell.
[30] G. Schieven,et al. Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the Pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. , 1991, The Journal of biological chemistry.
[31] A. Saxon,et al. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. , 1991, Journal of immunology.
[32] J. Banchereau,et al. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen , 1991, The Journal of experimental medicine.
[33] J. Ledbetter,et al. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. , 1990, Blood.
[34] S. Katz,et al. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. , 1987, Reviews of infectious diseases.
[35] H. Ochs,et al. Echovirus encephalitis/myositis in X-linked agammaglobulinemia. , 1985, The New England journal of medicine.
[36] S Ferrai,et al. Mutation of CD40 gene cause a novel autosomal recessive form of hyper IgM , 2001 .
[37] L. Notarangelo,et al. Immunodeficiency with hyper-IgM (HIM). , 1992, Immunodeficiency reviews.